67 



endangered plant species, by our reading appears to be adequate and we 

 urge its reauthorization. 



Conclusion 



As a health-care company, we find ourselves with many research 

 opportunities before us. Modern biological research tools are providing 

 us with unprecedented opportunities to make great strides in the 

 development of novel therapeutic agents for the treatment of human 

 diseases. We believe that plants will play an important role in the 

 development of such novel agents. Our own experience shows that it 

 is impossible to determine before the fact which individual species may 

 or may not be useful for some current or future propose. Consequently, 

 it will be important to ensure that endangered species are protected, yet 

 at the same time, are available for medicinal study. Pfizer's collaboration 

 with The New York Botanical Garden seeks to accomplish both of these 

 objectives. 



